The Britart mavericks have now teamed up with an unlikely artist. Is their odd throuple an elaborate prank – or are the duo passing down their legacy?

Analyst/Investor Day June 25, 2026 9:00 AM EDTCompany ParticipantsRyan GhazaeriSachin Lawande - President, CEO & ...

Strong earnings support U.S. stocks, but inflation and higher energy prices are increasing expectations for higher-for-longer interest rates.

A stealthy, fifth-generation fighter jet hunting radar systems sounds like something from a Tom Clancy novel — but it’s the ...

Working past 67 and Social Security can work in your favor. Here's what happens to your benefits, earnings limits, and ...

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.

To survive in the human host, bacteria have developed many different strategies to escape the innate immune response, including the expression of an extracellular capsule and 'hiding' within host ...

The human complement system has a pivotal role in the recognition, opsonization and elimination of microbial intruders. This functionality is maintained by a well-balanced interaction network of serum ...

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Eric's career includes extensive work in ...

You may have heard about the dreaded ‘Terrible Twos’, from other parents or healthcare professionals. Or maybe you’ve experienced them or are experiencing them right now. Well, we can reassure you ...